Nasal biphasic positive airway pressure vs. nasal continuous positive airway pressure following extubation in infants less than 30 weeks gestation
| ISRCTN | ISRCTN18921778 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN18921778 |
| Protocol serial number | 10146 |
| Sponsor | Central Manchester University Hospitals NHS Trust (CMFT) (UK) |
| Funder | National Institute for Health Research (NIHR) (UK)- Research for Patient Benefit Grant |
- Submission date
- 07/06/2011
- Registration date
- 07/06/2011
- Last edited
- 08/10/2018
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Neonatal Diseases
Plain English summary of protocol
Not provided at time of registration
Contact information
Scientific
St Mary's Hospital
Manchester Royal Infirmary
Oxford Road
Manchester
M13 9WL
United Kingdom
| suresh.victor@cmft.nhs.uk |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised; Interventional; Design type: Not specified |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | A randomised controlled trial of nasal biphasic positive airway pressure vs. nasal continuous positive airway pressure following extubation in infants less than 30 weeks gestation |
| Study acronym | EXTUBATE |
| Study objectives | Babies born prematurely have breathing difficulties for which they need support from a machine called ventilator. The ventilator gives them regular breaths through a breathing tube placed in the wind pipe. The process of removing the tube or extubation and allowing the baby to breathe on his/her own does not always go to plan. Around one-fourth of babies need to have the breathing tube replaced in the wind pipe. The process of replacing the tube can be traumatic and spending more time on the ventilator can damage the babys immature lungs. Continuous Positive Airway Pressure (n-CPAP) and Biphasic Positive Airway Pressure (n-BiPAP) are ways of supporting breathing that are less invasive - they use tubes that go only a few millimetres into the nostril. n-CPAP produces a constant pressure at the nose that is transmitted to the lungs. n-BiPAP produces a constant pressure and also gives extra breaths. We want to find out if these extra breaths will give the baby the added support needed to stay off the ventilator. We will conduct a randomised trial at several regional centres in the north-west of England. Babies born before 30 weeks gestation and less than two weeks old will be eligible to participate in the study. We will randomly assign babies to receive either n-CPAP or n-BiPAP to see which of these devices allows the baby to breathe most comfortably and stay off the ventilator. Early and successful extubation would mean that premature babies will spend less time on the ventilator. This will reduce the chances of injury to the babys lungs and allow for more efficient use of intensive care cots at referral centres. It would also mean that babies can be moved earlier to centres closer to home. |
| Ethics approval(s) | North West 11 Research ethics committee, Preston approved on 4th Jan 2011, 10/H1016/145 |
| Health condition(s) or problem(s) studied | Topic: Reproductive Health and Childbirth, Generic Health Relevance and Cross Cutting Themes; Subtopic: Reproductive Health and Childbirth (all Subtopics), Generic Health Relevance (all Subtopics); Disease: Reproductive Health & Childbirth, Paediatrics |
| Intervention | BiPAP: The BiPAP group will receive at extubation a mean airway pressure of 6 cm water (positive end expiratory pressure of 4 cm water and peak inspiratory pressure of 8 cms of water). Inspiratory time of one second and respiratory rate of 30/ min will always be maintained. CPAP: The CPAP group will receive at extubation a single level continuous positive airway pressure of 6 cm water for at least 48 hours before weaning is commenced. Study Entry: Single Randomisation only |
| Intervention type | Other |
| Primary outcome measure(s) |
Extubation Failure; Timepoint(s): This will be defined as: Uncompensated respiratory acidosis defined as pH less than 7.2 |
| Key secondary outcome measure(s) |
1. Maintenance of successful extubation for 7 days |
| Completion date | 31/03/2014 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Neonate |
| Sex | All |
| Target sample size at registration | 540 |
| Key inclusion criteria | 1. Born before 30 weeks gestation 2. Ventilated through an endotracheal tube 3. Less than two weeks old 4. First attempt at extubation Target Gender: Male & Female; Upper Age Limit 30 weeks ; Lower Age Limit 23 weeks |
| Key exclusion criteria | 1. Presence of major congenital malformations 2. Presence of neuromuscular disease 3. Presence of known upper respiratory tract abnormalities 4. Likely to be within 7 days post-operative 5. Presence of intraventricular haemorrhage with parenchymal extension |
| Date of first enrolment | 01/04/2011 |
| Date of final enrolment | 31/03/2014 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
M13 9WL
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/08/2016 | Yes | No | |
| Protocol article | protocol | 09/12/2011 | Yes | No | |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
08/10/2018: Publication reference added.